Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3Q8IDY4
Term | Name | Level | Count |
---|---|---|---|
GO:0002161 | aminoacyl-tRNA editing activity | 5 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0016787 | hydrolase activity | 2 | 12 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 12 |
GO:0052689 | carboxylic ester hydrolase activity | 4 | 12 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 12 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 12 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 12 |
GO:0004812 | aminoacyl-tRNA ligase activity | 4 | 2 |
GO:0016874 | ligase activity | 2 | 2 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 3 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 116 | 118 | PF00675 | 0.359 |
CLV_NRD_NRD_1 | 88 | 90 | PF00675 | 0.481 |
CLV_PCSK_FUR_1 | 86 | 90 | PF00082 | 0.383 |
CLV_PCSK_KEX2_1 | 116 | 118 | PF00082 | 0.359 |
CLV_PCSK_KEX2_1 | 88 | 90 | PF00082 | 0.488 |
CLV_PCSK_SKI1_1 | 117 | 121 | PF00082 | 0.378 |
CLV_PCSK_SKI1_1 | 130 | 134 | PF00082 | 0.228 |
DEG_SCF_TRCP1_1 | 93 | 99 | PF00400 | 0.368 |
DOC_ANK_TNKS_1 | 39 | 46 | PF00023 | 0.525 |
DOC_CYCLIN_yCln2_LP_2 | 188 | 194 | PF00134 | 0.483 |
DOC_PP2B_LxvP_1 | 102 | 105 | PF13499 | 0.508 |
DOC_PP2B_LxvP_1 | 120 | 123 | PF13499 | 0.301 |
DOC_PP2B_LxvP_1 | 225 | 228 | PF13499 | 0.462 |
DOC_SPAK_OSR1_1 | 24 | 28 | PF12202 | 0.424 |
DOC_USP7_MATH_1 | 51 | 55 | PF00917 | 0.675 |
DOC_USP7_MATH_1 | 9 | 13 | PF00917 | 0.619 |
LIG_14-3-3_CanoR_1 | 60 | 68 | PF00244 | 0.461 |
LIG_Actin_WH2_2 | 25 | 42 | PF00022 | 0.524 |
LIG_BRCT_BRCA1_1 | 97 | 101 | PF00533 | 0.324 |
LIG_CSL_BTD_1 | 102 | 105 | PF09270 | 0.423 |
LIG_FHA_1 | 227 | 233 | PF00498 | 0.532 |
LIG_FHA_1 | 97 | 103 | PF00498 | 0.466 |
LIG_FHA_2 | 138 | 144 | PF00498 | 0.452 |
LIG_FHA_2 | 262 | 268 | PF00498 | 0.466 |
LIG_LIR_Gen_1 | 150 | 160 | PF02991 | 0.437 |
LIG_LIR_Gen_1 | 247 | 256 | PF02991 | 0.467 |
LIG_LIR_Gen_1 | 98 | 109 | PF02991 | 0.486 |
LIG_LIR_Nem_3 | 150 | 156 | PF02991 | 0.437 |
LIG_LIR_Nem_3 | 247 | 251 | PF02991 | 0.435 |
LIG_LIR_Nem_3 | 98 | 104 | PF02991 | 0.337 |
LIG_MYND_1 | 72 | 76 | PF01753 | 0.557 |
LIG_SH2_SRC | 157 | 160 | PF00017 | 0.472 |
LIG_SH2_STAT5 | 153 | 156 | PF00017 | 0.437 |
LIG_SH2_STAT5 | 159 | 162 | PF00017 | 0.437 |
LIG_SH2_STAT5 | 231 | 234 | PF00017 | 0.507 |
LIG_SH3_3 | 75 | 81 | PF00018 | 0.619 |
LIG_SUMO_SIM_par_1 | 214 | 219 | PF11976 | 0.443 |
LIG_TRAF2_1 | 171 | 174 | PF00917 | 0.461 |
LIG_TRAF2_1 | 264 | 267 | PF00917 | 0.390 |
LIG_TYR_ITIM | 155 | 160 | PF00017 | 0.539 |
MOD_CK1_1 | 54 | 60 | PF00069 | 0.683 |
MOD_CK2_1 | 261 | 267 | PF00069 | 0.404 |
MOD_Cter_Amidation | 179 | 182 | PF01082 | 0.237 |
MOD_GlcNHglycan | 201 | 204 | PF01048 | 0.353 |
MOD_GlcNHglycan | 29 | 32 | PF01048 | 0.465 |
MOD_GlcNHglycan | 93 | 96 | PF01048 | 0.373 |
MOD_GSK3_1 | 195 | 202 | PF00069 | 0.531 |
MOD_GSK3_1 | 216 | 223 | PF00069 | 0.522 |
MOD_GSK3_1 | 257 | 264 | PF00069 | 0.387 |
MOD_GSK3_1 | 50 | 57 | PF00069 | 0.671 |
MOD_GSK3_1 | 91 | 98 | PF00069 | 0.311 |
MOD_N-GLC_1 | 147 | 152 | PF02516 | 0.257 |
MOD_NEK2_1 | 128 | 133 | PF00069 | 0.437 |
MOD_NEK2_1 | 134 | 139 | PF00069 | 0.437 |
MOD_PKA_2 | 249 | 255 | PF00069 | 0.613 |
MOD_PKA_2 | 59 | 65 | PF00069 | 0.629 |
MOD_Plk_1 | 147 | 153 | PF00069 | 0.432 |
MOD_Plk_1 | 54 | 60 | PF00069 | 0.693 |
MOD_Plk_4 | 128 | 134 | PF00069 | 0.444 |
MOD_Plk_4 | 226 | 232 | PF00069 | 0.440 |
TRG_ENDOCYTIC_2 | 152 | 155 | PF00928 | 0.438 |
TRG_ENDOCYTIC_2 | 157 | 160 | PF00928 | 0.436 |
TRG_ER_diArg_1 | 115 | 117 | PF00400 | 0.351 |
TRG_ER_diArg_1 | 86 | 89 | PF00400 | 0.476 |
TRG_NES_CRM1_1 | 16 | 29 | PF08389 | 0.428 |
TRG_Pf-PMV_PEXEL_1 | 170 | 174 | PF00026 | 0.309 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I030 | Leptomonas seymouri | 72% | 100% |
A0A0S4IHR6 | Bodo saltans | 46% | 100% |
A0A1X0NXR2 | Trypanosomatidae | 47% | 100% |
A0A422NWD3 | Trypanosoma rangeli | 50% | 100% |
A4HK97 | Leishmania braziliensis | 79% | 100% |
D0A1C2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 100% |
E9AGV9 | Leishmania infantum | 97% | 100% |
E9AV75 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
Q4QCA6 | Leishmania major | 90% | 100% |
V5B6I0 | Trypanosoma cruzi | 48% | 100% |